Sep 23,2021

Pear Therapeutics Announces Additional Coverage Decisions And Formulary Adoption Of Its Prescription Digital Therapeutics

Pear Therapeutics, Inc., the leader in developing and commercializing prescription digital therapeutics (PDTs) to treat serious disease, today updated the number of entities providing coverage for its three commercial products, reSET®, reSET-O®, and Somryst®. With these new coverage decisions, there are now more than 30 organizations that are providing access to Pear’s PDTs by either listing on formulary, as a covered benefit, or purchasing products in bulk.

PRODUCT

#reimbursement

#pdt

View Analyst & Ambassador Comments
Go to original news
Sep 23,2021

Digital Therapeutics Alliance Announces New Resource Partner Program to Accelerate Access and Impact of Digital Therapeutics for Patients Worldwide

Today, the Digital Therapeutics Alliance (DTA), a global non-profit trade association of industry leaders and stakeholders with the mission of broadening the understanding, adoption, and integration of digital therapeutics into healthcare, announced the launch of the DTA Resource Partner Program. Today’s announcement named EVERSANA, the pioneer of next generation commercial services to the global life sciences industry, as one of the first partners in the program. As a Resource Partner, EVERSANA, will begin by supporting DTA’s work to map global regulatory and reimbursement pathways for DTx products, to help members inform their strategic approach to achieve regulatory milestones that best fit their products.

#reimbursement

View Analyst & Ambassador Comments
Go to original news
Oct 13,2021

Pear Therapeutics Announces First State Medicaid Program Decision To Cover Prescription Digital Therapeutics

Pear Therapeutics, Inc. today announced MassHealth, Massachusetts’ Medicaid program, has notified Pear of its intent to cover Pear’s prescription digital therapeutics (PDTs) reSET® and reSET-O® to fight the growing substance and opioid addiction crisis. MassHealth has approximately two million Massachusetts residents enrolled.

PRODUCT

#pdt

#mobile app

#reimbursement

View Analyst & Ambassador Comments
Go to original news
Oct 15,2021

Scotland offers access to Big Health's DTx for anxiety, insomnia

Scotland is making a cognitive behavioral therapy app for anxiety and insomnia available to all adults in the country, marking a major validation of digital therapeutics to treat behavioral health conditions. Scotland's National Health Service (NHS) will offer national access to products from digital therapeutic maker Big Health at no cost to the user. About 5 million people will be eligible for access to Sleepio, the company’s app to treat insomnia with cognitive behavioral therapy, and Daylight, which is focused on combating worry and anxiety.

PRODUCT

#reimbursement

#mobile app

#cbt

View Analyst & Ambassador Comments
Go to original news
Oct 21,2021

Digital therapeutic 'HelloBetter Stress and Burnout' available to 50 million adults in Germany

Digital therapeutic course 'HelloBetter Stress and Burnout' has been approved by the Federal Institute for Drugs and Medical Devices as a Digital Health Application (DiGA). 'HelloBetter Stress and Burnout' is a digital health intervention for the treatment of stress, exhaustion, insomnia and depression. It is now integrated into Germany’s health system and can be offered as a course of treatment by therapists and doctors.

PRODUCT

#reimbursement

#cbt

#mobile app

View Analyst & Ambassador Comments
Go to original news
Nov 04,2021

Pear Therapeutics Announces Milestone Decision By The American Medical Association CPT Editorial Panel

Pear Therapeutics, Inc. is pleased to share that the American Medical Association (AMA) Current Procedural Terminology (CPT) Editorial Panel has announced revisions to existing CPT codes clarifying the coding of remote therapeutic monitoring for cognitive behavioral therapy (CBT) services. The changed codes may be applicable to the work of HCPs monitoring therapy adherence and therapy response with respect to Pear’s commercially available PDTs, reSET®, reSET-O® and Somryst® for the treatment of substance use disorder, opioid use disorder, and chronic insomnia, respectively, including the healthcare provider’s ability to remotely monitor progress.

PRODUCT

#reimbursement

#pdt

View Analyst & Ambassador Comments
Go to original news
Nov 09,2021

Pear Therapeutics Announces Inclusion of Reset® And Reset-O® on Masshealth Non-Drug Product List

Pear Therapeutics, Inc. today announced the inclusion of Pear’s FDA-authorized prescription digital therapeutics (PDTs) reSET® and reSET-O® on the November 2021 MassHealth Drug List Summary Update. reSET and reSET-O have been added to the MassHealth Non-Drug Product List and are now covered by MassHealth, effective November 1, 2021. Pear’s reSET and reSET-O will be paid for through MassHealth’s Pharmacy Online Processing System (POPS) and do not require prior authorization.

PRODUCT

#pdt

#reimbursement

View Analyst & Ambassador Comments
Go to original news
Nov 22,2021

5 Digital Therapeutics Updates to Read Right Now

For payers who want to learn more about emerging and technology-based treatments, the Digital Therapeutics Alliance (DTA) is an aggregated source for news and guidance. The following summarizes DTA's current and forthcoming resources, plus recent innovations from association members.

#pdt

#reimbursement

View Analyst & Ambassador Comments
Go to original news
Dec 14,2021

HelloBetter Diabetes and Depression – new, highly effective, digital therapy option available on prescription in Germany

HelloBetter Diabetes and Depression, the first online therapy course for the treatment of depressive symptoms in people with type 1 and 2 diabetes, is now eligible for prescription and reimbursement. Physicians and psychotherapists can thus prescribe the Digital Health Application (“DiGA”) on prescription.

PRODUCT

#reimbursement

#cbt

#mobile app

View Analyst & Ambassador Comments
Go to original news
Dec 22,2021

2022 forecast: The next hot areas for digital health investing

Here are five digital health markets to watch as investors look to pour major cash into the healthcare sector.

#virtual care

#rpm

#reimbursement

View Analyst & Ambassador Comments
Go to original news
Subscribe to REIMBURSEMENT